scholarly article | Q13442814 |
P356 | DOI | 10.3233/JAD-160285 |
P698 | PubMed publication ID | 27372646 |
P50 | author | Philip Scheltens | Q22280357 |
Max L Stek | Q114430698 | ||
Welmoed A Krudop | Q114430713 | ||
Cora J Kerssens | Q114430714 | ||
Everard G B Vijverberg | Q114430758 | ||
Frederik Barkhof | Q42355589 | ||
Niels D Prins | Q48357915 | ||
Flora Gossink | Q86593918 | ||
Annemiek Dols | Q89600001 | ||
Mike P. Wattjes | Q96171523 | ||
Yolande A L Pijnenburg | Q97517231 | ||
Bart N M van Berckel | Q100745139 | ||
P2093 | author name string | Anne Peters | |
Christiane Möller | |||
P2860 | cites work | Classification of primary progressive aphasia and its variants | Q24594803 |
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia | Q24598142 | ||
Hippocampal atrophy in recurrent major depression | Q24598190 | ||
Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion | Q24633898 | ||
“Mini-mental state” | Q25938989 | ||
The positive and negative syndrome scale (PANSS) for schizophrenia | Q28301751 | ||
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q29547554 | ||
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium | Q29614409 | ||
A New Depression Scale Designed to be Sensitive to Change | Q29614720 | ||
Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration | Q33685317 | ||
The FAB: a Frontal Assessment Battery at bedside. | Q33927821 | ||
Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update | Q34020227 | ||
Anatomy of bipolar disorder and schizophrenia: a meta-analysis. | Q34092580 | ||
The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease | Q34792591 | ||
Brain atrophy over time in genetic and sporadic frontotemporal dementia: a study of 198 serial magnetic resonance images | Q35327928 | ||
Visual assessment of posterior atrophy development of a MRI rating scale | Q35552599 | ||
The Phenotype of the C9ORF72 Expansion Carriers According to Revised Criteria for bvFTD. | Q35683082 | ||
Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's disease | Q36142251 | ||
MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases | Q36724441 | ||
FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease | Q36912674 | ||
A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series | Q36960858 | ||
Characterizing radiology reports in patients with frontotemporal dementia | Q37368361 | ||
Differential effects of electrical stimulation of sciatic nerve on metabolic activity in spinal cord and dorsal root ganglion in the rat. | Q37532084 | ||
Clinical significance of lobar atrophy in frontotemporal dementia: application of an MRI visual rating scale | Q38398448 | ||
Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort | Q39675579 | ||
Regional cerebral glucose utilization in patients with a range of severities of unipolar depression | Q42172014 | ||
Accuracy of the clinical evaluation for frontotemporal dementia | Q43548904 | ||
Changes in cortical thickness during the course of illness in schizophrenia. | Q45927962 | ||
Identifying bvFTD Within the Wide Spectrum of Late Onset Frontal Lobe Syndrome: A Clinical Approach | Q48084340 | ||
11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration | Q48210315 | ||
MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging | Q48225787 | ||
Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer's disease | Q48298121 | ||
18F-florbetapir PET in patients with frontotemporal dementia and Alzheimer disease. | Q48342259 | ||
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop | Q48342894 | ||
The Stereotypy Rating Inventory for frontotemporal lobar degeneration | Q48584248 | ||
Antemortem diagnosis of frontotemporal lobar degeneration | Q48957288 | ||
Regional brain volume in depression and anxiety disorders | Q49018204 | ||
Clinical Approach to the Differential Diagnosis Between Behavioral Variant Frontotemporal Dementia and Primary Psychiatric Disorders | Q50345784 | ||
Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: interobserver reliability. | Q52886859 | ||
The added value of 18-fluorodeoxyglucose-positron emission tomography in the diagnosis of the behavioral variant of frontotemporal dementia. | Q53077511 | ||
Contribution of asymmetric synapse loss to lateralizing clinical deficits in frontotemporal dementias. | Q53243461 | ||
Frontotemporal dementia associated with the C9ORF72 mutation: a unique clinical profile | Q56770874 | ||
P433 | issue | 4 | |
P921 | main subject | frontotemporal dementia | Q18592 |
dementia | Q83030 | ||
behavioural change | Q110771776 | ||
Fluorodeoxyglucose Positron Emission Tomography | Q130273243 | ||
P304 | page(s) | 1287-1297 | |
P577 | publication date | 2016-06-30 | |
P1433 | published in | Journal of Alzheimer's Disease | Q6294755 |
P1476 | title | Diagnostic Accuracy of MRI and Additional [18F]FDG-PET for Behavioral Variant Frontotemporal Dementia in Patients with Late Onset Behavioral Changes | |
P478 | volume | 53 |
Q52644592 | Amsterdam Dementia Cohort: Performing Research to Optimize Care. |
Q37703133 | Cerebrospinal fluid biomarker examination as a tool to discriminate behavioral variant frontotemporal dementia from primary psychiatric disorders |
Q34558884 | Dementia prevention, intervention, and care. |
Q61443228 | Dual-phase [18F]florbetapir in frontotemporal dementia |
Q93083717 | FTD spectrum: Neuroimaging across the FTD spectrum |
Q38670219 | Imaging and fluid biomarkers in frontotemporal dementia. |
Q57039891 | Morphometric MRI as a diagnostic biomarker of frontotemporal dementia: A systematic review to determine clinical applicability |
Q51800676 | Neuroimaging in Dementia. |
Q90029747 | Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders |
Q48031199 | The Pitfall of Behavioral Variant Frontotemporal Dementia Mimics Despite Multidisciplinary Application of the FTDC Criteria |
Q92856453 | The Use of Biomarkers and Genetic Screening to Diagnose Frontotemporal Dementia: Evidence and Clinical Implications |
Search more.